Wound care company sees potential in regenerative medicine

02/9/2011 | Today's Wound Clinic magazine

Advanced BioHealing makes Dermagraft -- a wound care product that contains living human fibroblast cells, an extracellular matrix and an absorbable scaffold -- which is approved to treat diabetic foot ulcers and is in clinical trials for healing venous leg ulcers, Senior Vice President Dean Tozer said. "This approach to healing wounds is a prime example of the potential of the emerging field regenerative medicine," Tozer said in this interview with Today's Wound Clinic. The company also developed a community health education program to raise awareness about diabetic foot ulcers.

View Full Article in:

Today's Wound Clinic magazine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL